You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Madeleine covers PCR, nucleic acid amplification, and sample prep technologies for GenomeWeb.
A handful of researchers and companies are hoping to finally bring the paper-based molecular diagnostic space to fruition.
The move is intended to increase testing for COVID-19 and may help conserve resources, which were a major problem during the height of the pandemic.
More than a dozen studies have been published to date directly comparing molecular diagnostic COVID-19 tests, with some detecting differences, mostly in sensitivity.
A handful of recently published trials suggest that use of the pneumonia panel could lead to more targeted therapy delivered more quickly than standard methods.
The acquisition will round out BD's molecular portfolio and be complementary to the firm's Veritor immunoassay system, according to executives.
With the US now awash in positive samples, assay developers seeking authorization will no longer be allowed to use contrived samples.
The firm's Continuum system is fully automated and performs the entire digital PCR workflow in a single instrument.
The partners received Emergency Use Authorization last week for a test that uses oral fluids, and the lab has capacity to test up to 10,000 samples per day.
The agency plans to work with a number of partners to develop codes that will describe tests and results to standardize data collection.
MBS has developed a compact endpoint PCR system which can test more than 22,000 patient samples per day by performing eight-minute thermal cycling.
Researchers have developed a robotic lab assistant, the Verge reports.
CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.
The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.
In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.